'Multinational drug companies have been lobbying ministers in an attempt to subvert the independent appraisal process and get their expensive new medicines approved for large-scale use in the NHS, the Guardian can reveal.
Over the eight months from October to May this year, senior executives from 10 drug companies met ministers to press for favourable decisions on their products.'
